THE ROLE OF TOPOISOMERASE [IIA] AS A PREDICTIVE FACTOR FOR RESPONSE TO NEOADJUVANT ANTHRACYCLINES BASED CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER

被引：0

作者：

Gamea, Mohamed ^{[1
]}

机构：

[1] Tanta Univ, Tanta, Gharbia, Egypt

来源：

Asia-Pacific Journal of Clinical Oncology | 2015年 / 11卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

198

引用

页码：123 / 123

页数：1

共 50 条

[1] The role of topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer
Gamea, M.
[J]. EUROPEAN JOURNAL OF CANCER, 2017, 72 : S37 - S37
[2] The role of Topoisomerase II-α (TOPO IIA) as a predictive factor of response neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer
Gamea, M.
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 140 - 141
[3] The role of Topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer
Gamea, M.
[J]. EUROPEAN JOURNAL OF CANCER, 2018, 92 : S111 - S111
[4] The role of Topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer
Gamea, M. M.
[J]. EUROPEAN JOURNAL OF CANCER, 2018, 92 : S12 - S13
[5] THE ROLE OF TOPOISOMERASE II-A (TOPO IIA) AS A PREDICTIVE FACTOR FOR RESPONSE TO NEOADJUVANT ANTHRACYCLINES BASED CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER
Gamea, M.
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 614 - 614
[6] The role of topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracycline-based chemotherapy in locally advanced breast cancer
Gamea, M. M.
[J]. ANNALS OF ONCOLOGY, 2018, 29 : 28 - 28
[7] The role of topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracycline-based chemotherapy in locally advanced breast cancer
Gamea, M.
[J]. ANNALS OF ONCOLOGY, 2018, 29 : 33 - 33
[8] Topoisomerase II-α as a predictive factor of response to therapy with anthracyclines in locally advanced breast cancer
Gomez, Henry L.
Pinto, Joseph A.
Olivera, Mivael
Vidaurre, Tatiana
Doimi, Franco D.
Vigil, Carlos E.
Velarde, Raul G.
Abugattas, Julio E.
Alarcon, Edith
Vallejos, Carlos S.
[J]. BREAST, 2011, 20 (01): : 39 - 45
[9] Neo-adjuvant anthracycline based chemotherapy in locally advanced breast cancer: assessment of topoisomerase IIA with response
Singer, J.
Dewdney, A.
Mapp, L.
Bradpiece, H. A.
Jenkins, S.
Jader, S.
Patel, A.
[J]. EJC SUPPLEMENTS, 2009, 7 (02): : 311 - 311
[10] Predictive markers of response to neoadjuvant chemotherapy in locally advanced breast cancer (LAPC)
Mukherjee, A.
Shehata, M.
Sharma, R.
Rakha, E.
Ellis, I.
Ball, G.
Ball, B. M.
Chan, S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →